Inventor · disambiguated record
Siobhan H. O'Brien
Also filed as: O'BRIEN SIOBHAN · O'BRIEN SIOBHAN H
8 granted patents·7 pending applications·259 citations·filing 2000–2022
89Inventor score
Files withMILLENNIUM PHARM INC9LAROSA GREGORY J2UNIV COLUMBIA2GOVERNING COUNCIL UNIV TORONTO1MEDIMMUNE LTD1
Top patents by PatentIndex Score
15 records- 0198US6696550B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Granted Feb 24, 2004·135 cites·74 claims
- 0297US6727349B1Recombinant anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2000·Granted Apr 27, 2004·81 cites·62 claims
- 0390US7442775B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Oct 28, 2008·15 cites·38 claims
- 0489US7566450B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2007·Granted Jul 28, 2009·6 cites·18 claims
- 0587US7473421B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Jan 6, 2009·11 cites·23 claims
- 0686US11530257B2Chimeric antibodies for treatment of amyloid deposition diseasesUNIV COLUMBIA·Filed 2018·Granted Dec 20, 2022·5 cites·8 claims
- 0785US8227211B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2008·Granted Jul 24, 2012·5 cites·23 claims
- 0875US8926971B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2012·Granted Jan 6, 2015·1 cites·23 claims
- 0969US2015086546A1Humanized anti-ccr2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 1067US2023212273A1Chimeric antibodies for treatment of amyloid deposition diseasesUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 1167US2008268536A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1267US2008241923A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1362US2009169541A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1445US2016185837A1Gip and glp-1 receptor dual-agonists for the treatment of diabetesMEDIMMUNE LTD·Filed 2014·Application pending·0 cites
- 1542US2023042367A1Methods and compositions for treating cancers having f-box and wd-repeat protein 7 (fbxw7) alterations and/or cyclin l1 (ccnl1) gain or amplificationGOVERNING COUNCIL UNIV TORONTO·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →